Showing results (1091-1100 of 10,440) with videos related to

Sort By:
Pageof 1,044
AIDS (London, England)|June 29, 2018
Implementation science for integration of HIV and non-communicable disease services in sub-Saharan Africa: a systematic reviewChristopher G Kemp, Bryan J Weiner, Kenneth H Sherr, et al.
AIDS (London, England)|June 30, 2018
Time spent with HIV viral load above 1500 copies/ml among patients in HIV care, 2000-2014Maria C B Mendoza, Lytt Gardner, Carl Armon, et al.
AIDS (London, England)|May 31, 2018
Unconditional cash transfers for clinical and economic outcomes among HIV-affected Ugandan householdsEdward J Mills, Achyuta Adhvaryu, Pamela Jakiela, et al.
AIDS (London, England)|May 31, 2018
C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South AfricaAdrienne E Shapiro, Ting Hong, Sabina Govere, et al.
AIDS (London, England)|November 6, 2003
Cytomegalovirus-specific IFN-gamma production is associated with protection against cytomegalovirus reactivation in HIV-infected patients on highly active antiretroviral therapyAdriana Weinberg, David A Wohl, Samantha MaWhinney, et al.
AIDS (London, England)|November 6, 2003
Tuberculosis epidemics driven by HIV: is prevention better than cure?Christine S M Currie, Brian G Williams, Russell C H Cheng, et al.
AIDS (London, England)|November 6, 2003
HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of ChinaBo Su, Li Liu, Fusheng Wang, et al.
AIDS (London, England)|October 21, 2003
Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'IvoireGaston Djomand, Thierry Roels, Tedd Ellerbrock, et al.
AIDS (London, England)|October 21, 2003
Prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients who have rebound in viral load while receiving antiretroviral therapy in the UNAIDS-Drug Access Initiative in Abidjan, Côte d'IvoireChristiane Adjé-Touré, Bilé Celestin, Debra Hanson, et al.
AIDS (London, England)|October 23, 2003
Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjectsJosiah Eyeson, Deborah King, Mark J Boaz, et al.
Pageof 1,044